Drugs/Recall·openFDA/drug

Safecor Health, LLC — Class II: Fluphenazine HCl Elixir, USP, 5 mg per 1 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14

MediumPublished Sep 23, 2026· AI-analyzed Sep 29, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Safecor Health, LLC has initiated a Class II recall for Fluphenazine HCl Elixir (5 mg per 1 mL, 10 mL delivery) due to failed stability specifications. The recall is currently listed as ongoing for the affected NDC: 00121-0653-04.

Who it affects

This recall affects Safecor Health, LLC, healthcare facilities, and pharmacies utilizing this specific repackaged fluphenazine elixir, as well as quality control departments responsible for stability monitoring.

Why it matters

A Class II recall for failed stability suggests that the product may not maintain its potency, purity, or identity throughout its labeled shelf life. For regulatory and quality professionals, this indicates a potential breakdown in the stability testing program or a formulation issue that could impact therapeutic efficacy, though the risk of serious adverse health consequences is generally considered remote in Class II scenarios.

Practical takeaway

Quality and supply chain teams should immediately identify and sequester the specified NDC (00121-0653-04). QA should review stability data for similar liquid formulations to ensure current monitoring programs remain robust enough to detect out-of-specification trends before distribution.

FDA source material

Class II. Reason: Failed Stability Specifications. Product: Fluphenazine HCl Elixir, USP, 5 mg per 1 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0653-04. Firm: Safecor Health, LLC (Woburn MA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.